Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q4 2025?

125 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 46,682,919
Total 13F value: $359,443,900
Share change: +5,032,183
Put/Call ratio: 122%
SEC-reported price per share: $7.70
Number of holders: 125
Value change: +$38,829,151
Number of buys: 72
Number of sells: 35
Shares outstanding: 91,091,040

Security key

221015100

Report period

Q4 2025

Institutions

125

Top holders

CRVS full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Corvus Pharmaceuticals, Inc. SEC filings Corvus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 221015100

Newer quarter: Q1 2026 Previous quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Richard A. Miller MD

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

31 Dec 2025

13D/G 13F 3/4/5 Lead comparable stake: 7.8% 13D/G row: Richard A. Miller MD Showing 1-6 of 15 holder rows.

Quick read

Richard A. Miller MD leads the comparable SEC ownership view at 7.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Richard A. Miller MD's linked filing trail.

Comparable ownership Top 5

Richard A. Miller MD 7.8%

ORBIMED ADVISORS LLC 7.9%

Point72 Asset Management, L.P. 7.1%

BlackRock, Inc. 5.2%

VANGUARD GROUP INC 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Richard A. Miller MD	13D/G Richard A. Miller 13D/G	7.8%	$40,653,959 6,085,922 shares	+$5,781,901	31 Dec 2025
ORBIMED ADVISORS LLC	13F 3/4/5 Company · Director, 10%+ Owner 13F 3/4/5	7.9% from 3/4/5	$52,806,094 7,165,006 shares	—	30 Sep 2025
Point72 Asset Management, L.P.	13F Company 13F	7.1%	$47,567,999 6,454,274 shares	—	30 Sep 2025
BlackRock, Inc.	13F Company 13F	5.2%	$34,715,958 4,710,442 shares	—	30 Sep 2025
VANGUARD GROUP INC	13F Company 13F	3.8%	$25,588,088 3,471,925 shares	—	30 Sep 2025
ADAMS STREET PARTNERS LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	3.6%	$24,141,290 3,275,616 shares	—	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

125

46,682,919

Rows available

125

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

101

Q4 2025 holders

125

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend